Literature DB >> 25215163

Effects of ramipril on ventricular arrhythmia after myocardial infarction in rabbits.

Ya Zhong1, Ping Cao1, Chuan-Feng Tong1, Xia Li1.   

Abstract

BACKGROUND: Ventricular arrhythmia (VA) is one of the most common complications of myocardial infarction (MI), and ventricular tachycardia and fibrillation are the main causes for sudden cardiac death. This study aimed to explore the effect of ramipril on the occurrence of VA and its mechanism after MI in rabbits.
METHODS: Twenty-four New Zealand rabbits purchased from the Wuhan Laboratory Animal Research Center were divided into three groups: sham-operated (SHAM) group (n=8), MI group (n=8) and MI with ramipril (RAM) group (n=8). Rabbits in the SHAM group received a median sternotomy without ligation of the left ventricular coronary artery. Rabbits in the MI and RAM groups received a median sternotomy followed by ligation of the left coronary artery. The successful anterior MI was confirmed by elevation of the ST segment with more than 0.2 mV in lead II and III. After MI, rabbits in the RAM group were fed with intragastric ramipril (1 mg/kg per day) for 12 weeks. Before and 12 weeks after MI in the three groups, ventricular tachycardia or fibrillation (VT/VF) episodes and MAP in cadiocytes of the epicardium, mid-myocardium and endocardium were recorded by a multichannel physiograph. Student's t test and ANOVA were used for statistical analysis.
RESULTS: VT/VF episodes were decreased more markedly in the RAM group than in the MI group after 12 weeks (2.6±0.8 vs. 12.4±2.9, P<0.05). Twelve weeks after MI, the duration of repolarization for 90% (APD90) of three-tier ventricular myocytes in the MI group was longer than that before MI (258.2±21.1 vs. 230.1±23.2, 278.0±23.8 vs. 245.8±25.4, 242.6±22.7 vs. 227.0±21.7, P<0.05). However, the APD90 was not significantly different at 12 weeks before and after MI in the RAM group (P>0.05). Moreover, the transmural dispersion of repolarization (TDR) was increased more markedly 12 weeks after MI in the MI group than in the SHAM and RAM groups (36.2±10.2 vs. 18.7±6.2, 24.9±8.7, P<0.05). But the TDR was not significantly different between the RAM and SHAM groups (18.7±6.2 vs. 24.9±8.7, P>0.05).
CONCLUSION: Ramipril may reduce the incidence of malignant ventricular arrhythmia via improvement of transmembrance repolarization heterogeneity after MI.

Entities:  

Keywords:  Monophasic action potential duration; Myocardial infarction; Rabbits; Ramipril; Transmural dispersion of repolarization; Ventricular arrhythmia

Year:  2014        PMID: 25215163      PMCID: PMC4129872          DOI: 10.5847/wjem.j.issn.1920-8642.2014.02.010

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  15 in total

Review 1.  Functional, structural, and dynamic basis of electrical heterogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and anti-arrhythmic drug therapy.

Authors:  R Wolk; S M Cobbe; M N Hicks; K A Kane
Journal:  Pharmacol Ther       Date:  1999-11       Impact factor: 12.310

Review 2.  Electrical heterogeneity within the ventricular wall.

Authors:  C Antzelevitch; J Fish
Journal:  Basic Res Cardiol       Date:  2001-11       Impact factor: 17.165

3.  A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell.

Authors:  S Sicouri; C Antzelevitch
Journal:  Circ Res       Date:  1991-06       Impact factor: 17.367

4.  Active compression-decompression cardiopulmonary resuscitation (CPR) versus standard CPR for cardiac arrest patients: a meta-analysis.

Authors:  Xu-Rui Luo; Hui-Li Zhang; Geng-Jin Chen; Wen-Shu Ding; Liang Huang
Journal:  World J Emerg Med       Date:  2013

5.  Ionic basis of ventricular arrhythmias in remodeled rat heart during long-term myocardial infarction.

Authors:  F Aimond; J L Alvarez; J M Rauzier; P Lorente; G Vassort
Journal:  Cardiovasc Res       Date:  1999-05       Impact factor: 10.787

6.  Hypertrophy induced alteration of action potential and effects of the inhibition of angiotensin converting enzyme by perindopril in infarcted rat hearts.

Authors:  C Thollon; P Kreher; V Charlon; A Rossi
Journal:  Cardiovasc Res       Date:  1989-03       Impact factor: 10.787

7.  Characteristics of I(K) and its response to quinidine in experimental healed myocardial infarction.

Authors:  F Yuan; J M Pinto; Q Li; B J Wasserlauf; X Yang; A L Bassett; R J Myerburg
Journal:  J Cardiovasc Electrophysiol       Date:  1999-06

8.  Left ventricular remodeling and ventricular arrhythmias after myocardial infarction.

Authors:  Martin St John Sutton; Douglas Lee; Jean Lucien Rouleau; Steven Goldman; Ted Plappert; Eugene Braunwald; Marc A Pfeffer
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

9.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

10.  Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction.

Authors:  Emeline Perrier; Benoît-Gilles Kerfant; Nathalie Lalevee; Patrice Bideaux; Michel F Rossier; Sylvain Richard; Ana María Gómez; Jean-Pierre Benitah
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.